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Overall, 670 cases (O) of childhood leukaemia were diagnosed within 20km of the 29 French nuclear installations between 1990 and
1998 compared to an expected number (E) of 729.09 cases (O/E¼0.92, 95% confidence interval (CI)¼[0.85–0.99]). Each of the
four areas defined around the sites showed non significant deficits of cases (0–5km: O¼65, O/E¼0.87, CI¼[0.67–1.10]; 5–10km:
O¼165, O/E¼0.95, CI¼[0.81–1.10]; 10–15km: O¼220, O/E¼0.88, CI¼[0.77–1.00]; 15–20km: O¼220, O/E¼0.96,
CI¼[0.84–1.10]). There was no evidence of a trend in standardised incidence ratio with distance from the sites for all children or for
any of the three age groups studied. Similar results were obtained when the start-up year of the electricity-generating nuclear sites
and their electric nuclear power were taken into account. No evidence was found of a generally increased risk of childhood leukaemia
around the 29 French nuclear sites under study during 1990–1998.
British Journal of Cancer (2004) 91, 916–922. doi:10.1038/sj.bjc.6602068 www.bjcancer.com
Published online 27 July 2004
& 2004 Cancer Research UK
Keywords: childhood leukaemia; nuclear sites; incidence
                                        
Reports of an increased incidence of leukaemia among young
people living near the nuclear site of Sellafield lead to an extensive
investigation of this area (COMARE, 1996) and the sites of
Dounreay (COMARE, 1988), Aldermaston and Burghfield (CO-
MARE, 1989), 20 years ago. Radiological studies showed that the
levels of radioactivity in these areas were far below those necessary
to account for the observed excesses (Dionan et al, 1986, 1987;
Simmonds et al, 1995). Kinlen (1988, 1995) and Kinlen et al (1995)
hypothesised that the high rates of population mixing due to the
construction of the sites may induce local epidemics of an
unknown infective agent. Although some results are consistent
with this hypothesis (Dickinson and Parker, 1999; Boutou et al,
2002), the underlying biological mechanism has yet to be
determined. Several studies have systematically examined the
evidence relating to all of a country’s nuclear installations.
Mortality studies in the USA (Jablon et al, 1991), Canada
(McLaughlin et al, 1993), France (Hattchouel et al, 1995), Spain
(Lopez-Abente et al, 1999) and Japan (Iwasaki et al, 1995), and
incidence studies in England and Wales (Bithell et al, 1994),
Scotland (Sharp et al, 1996), Germany (Michaelis et al, 1992;
Kaatsch et al, 1998), Sweden (Waller et al, 1995), Canada
(McLaughlin et al, 1993) and the USA (Jablon et al, 1991) found
no statistical evidence of an excess of leukaemia among children
living around nuclear sites. In France, despite indications of
increased incidence for certain combinations of age groups and
geographical areas, extensive investigation of the La Hague site
(Viel and Richardson, 1990; Viel et al, 1993, 1995; Pobel and Viel,
1997; Guizard et al, 2001; Boutou et al, 2002) finally yielded, as for
the Marcoule site (Bouges et al, 1999), no evidence of a significant
excess of cases of childhood leukaemia. The present paper reports
the first systematic study of the incidence of childhood leukaemia
around all 29 French nuclear installations.
MATERIALS AND METHODS
The study was designed to investigate the incidence of leukaemia
among children under 15 years of age living less than 20km away
from one of the 29 nuclear installations in France and, in
particular, to examine the existence of a trend in standardised
incidence ratio (SIR) with increasing distance from the sites.
It included all cases of acute leukaemia diagnosed between the
1st January 1990 and 31st December 1998 among children under 15
years of age living within the study area at diagnosis. They were
provided by the National Registry of Childhood Leukaemia and
Lymphoma (INSERM U170, J Clavel), which has registered all
cases diagnosed in France since 1st January 1990 (Clavel et al,
2004).
Table 1 lists the 29 French nuclear sites considered in this study.
Each of these sites included at least one ‘regulated nuclear facility’-
classified reactor in activity for 1 year at least during the study
period (1990–1998).
All 19 electricity-generating nuclear sites (EGNS), which are
owned and operated by ‘Electricite ´ de France’ (EDF), were started
up before the beginning of our study period except for Golfech
(1990), Penly (1990) and Civaux (1997). In addition to the start-up
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yyear, we considered the electric nuclear power (in electric mega
Watts (MWe)) of each of these sites, which is the sum of the power
of all the units on site (Table 1). Note that the site of Tricastin
started producing electricity in 1980, but it also includes plants
(such as Pierrelatte) involved in uranium enrichment and
conversion as well as other research activities, which started in
1960. The site of Bugey has also been referred to under the name of
St Vulbas (Hill and Laplanche, 1990); we shall follow the current
(and most common) usage and refer to it as Bugey.
The remaining 10 nuclear installations are of various types:
Romans-sur-Ise `re is a nuclear fuel-processing plant operated by
the ‘Socie ´te ´ Franco-Belge de Fabrication de Combustibles’ (FBFC),
Marcoule is a nuclear fuel-processing plant operated by the
‘Compagnie Ge ´ne ´rale des Matie `res Nucle ´aires’ (COGEMA) and also
includes research activities, La Hague is a nuclear fuel-reproces-
sing plant operated by COGEMA, Creys-Malville was a fast neutron
reactor designed to produce electricity and plutonium operated by
EDF, and the six remaining sites (Bruye `res-le-Chatel, Cadarache,
Fontenay-aux-Roses, Grenoble, Saclay and Valduc) are nuclear
research centres operated by the ‘Commissariat a ` l’Energie
Atomique’ (CEA).
A pooled analysis of the 29 sites was carried out, followed by an
individual study of each site. The 19 EGNS were analysed as a
separate subgroup because of their common characteristics.
Further analysis was carried out in this subgroup according to
the start-up year and electric nuclear power of the sites.
The areas under study were discs of radii 20km centred on the
nuclear sites. These were subsequently divided into concentric
bands (0–5, 5–10, 10–15 and 15–20km). The smallest adminis-
trative units for which sex- and age-specific population counts are
available in France are the ‘communes’. There are 36565
communes in France with an average population per commune
of 1609 inhabitants; 64% of all communes are considered rural
(average population of 600). The study areas were constructed as
aggregations of the communes whose town hall was within the
defined zones. The 5km bands were chosen because this accorded
with previous studies and without prior knowledge of the
geographical distribution of cases of leukaemia.
Table 1 Distribution according to distance of observed (O) and expected (E) cases of leukaemia among children aged 0–14 years living less than 20km
away from one of the 29 nuclear sites in France (1990–1998)
0–5km 5–10km 10–15km 15–20km Total
Nuclear sites (year
a, power
b) O E OEOEOEOE
EGNS:
Belleville (1987, 2600) 0 0.26 0 0.53 2 1.44 3 1.05 5 3.28
Bugey (1971, 3600) 0 0.21 2 2.62 5 3.67 7 5.58 14 12.07
Cattenom (1986, 5200) 0 0.92 5 5.95 3 4.25 3 6.48 11 17.61
Chinon (1963, 3600) 1 0.68 6 1.47 2 0.94 5 3.55 14 6.64
Chooz (1966, 2800) 0 0.59 0 0.75 0 0.54 0 0.01 0 1.90
Civaux (1997, 2800) 0 0.08 1 0.51 1 0.88 5 1.48 7 2.95
Cruas (1983, 3600) 0 0.48 3 3.21 4 2.20 3 3.18 10 9.07
Dampierre (1980, 3600) 0 0.38 2 1.48 1 1.02 0 1.07 3 3.95
Fessenheim (1977, 1800) 0 0.36 0 0.68 0 0.88 0 3.59 0 5.51
Flamanville (1985, 2600) 0 0.29 1 0.63 0 0.53 1 1.02 2 2.48
Golfech (1990, 2600) 0 0.53 1 0.57 1 0.87 2 2.37 4 4.33
Gravelines (1980, 5400) 1 1.67 2 2.03 6 6.49 5 10.12 14 20.31
Le Blayais (1981, 3600) 0 0.00 1 1.09 2 1.55 1 1.28 4 3.91
Nogent (1987, 2600) 1 0.55 2 0.60 0 0.77 1 2.98 4 4.90
Paluel (1984, 5200) 0 0.21 1 1.17 0 0.69 2 1.26 3 3.34
Penly (1990, 2600) 0 0.42 1 0.85 3 4.17 5 2.21 9 7.65
St Alban (1985, 2600) 4 1.69 4 2.56 0 1.88 4 9.59 12 15.72
St Laurent (1969, 1800) 1 0.43 0 1.28 2 1.36 2 1.41 5 4.48
Tricastin/Pierrelatte 0 0.88 2 3.17 1 2.09 1 0.79 4 6.92
(1980, 3600)
Total EGNS 8 10.64 34 31.13 33 36.21 50 59.03 125 137.01
SIR (95% CI) 0.75 (0.32–1.48) 1.09 (0.76–1.53) 0.91 (0.63–1.28) 0.85 (0.63–1.12) 0.91 (0.76–1.09)
Other nuclear sites
Cadarache (1963) 0 0.05 1 0.70 1 0.86 2 2.49 4 4.09
Creys-Malville (1985) 1 0.19 1 0.94 1 0.66 5 2.41 8 4.20
Grenoble (1956) 14 14.47 9 11.10 5 4.13 10 7.48 38 37.18
La Hague (1967) 2 0.31 0 0.43 1 0.73 2 5.22 5 6.69
Marcoule (1956) 0 0.19 5 4.89 5 2.11 1 1.95 11 9.14
Romans-sur-Ise `re (1962) 2 3.79 1 0.76 3 2.32 2 2.03 8 8.90
Valduc (1962) 0 0.03 0 0.09 0 0.21 0 0.64 0 0.96
Bruye `res/Saclay/Fontenay 38 45.43 114 124.25 171 203.54 148 147.68 471 520.91
(1955/1950/1948)
Subtotal (EGNS and other except B/S/F
c) 27 29.68 51 50.05 49 47.22 72 81.24 199 208.18
SIR (95% CI) 0.91 (0.60–1.32) 1.02 (0.76–1.34) 1.04 (0.77–1.37) 0.89 (0.69–1.12) 0.96 (0.83–1.10)
Total (EGNS and other) 65 75.11 165 174.30 220 250.76 220 228.92 670 729.09
SIR (95% CI) 0.87 (0.67–1.10) 0.95 (0.81–1.10) 0.88 (0.77–1.00) 0.96 (0.84–1.10) 0.92 (0.85–0.99)
EGNS¼electricity-generating nuclear sites; SIR¼standardised incidence ratio; (95% CI)¼95% confidence interval for the SIR.
aYear of start-up.
bElectric nuclear power in MWe
of an EGNS given by the number of units on site multiplied by the power of each unit.
cB/S/F¼Bruye `res/Saclay/Fontenay.
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yWhen the study areas around two sites overlapped (this
occurred six times), the communes were assigned to the nearest
of the two sites in order to maintain a strict partition of the
areas under study, thus ensuring independence of the statistical
tests. The nuclear research sites of Bruye `res-le-Cha ˆtel (B), Saclay
(S) and Fontenay (F) were treated differently as all three are
within close distance of each other (distance between B and F:
21.6km; B–S: 14.6km; S–F: 11.3km). As the three study areas
(discs of radii 20km) had considerable overlaps, we decided to
consider these sites collectively. The 0–5km zone contained the
communes whose distance to the closest of the three sites was less
than 5km, the same rule applying for each of the study zones.
Throughout the study these three nuclear plants were considered
as one site, which explains the reference to 27 sites rather than the
original 29. It should also be noted that the sites of Chooz and
Fessenheim are close, respectively, to the Belgian and to the
German borders, but only the French part of the area was taken
into account.
For each commune, age- and sex-specific population counts
were obtained from the French National Institute of Economic and
Statistical Studies (INSEE) for the March 1990 and March 1999
censuses, as well as the number of births according to sex (INSEE)
and the number of deaths according to sex and age (Ce ´piDc,
INSERM) for each year from 1990 to 1999. A diagonal interpola-
tion procedure (Benhamou and Laplanche, 1991) was developed in
order to obtain age-specific population estimates for years 1991–
1998 for each commune. Each of the individual age cohorts was
followed up from the 1990 census or from birth by ageing 1 year at
a time and subtracting the number of deaths, which occurred
during that year in the given age cohort. We estimated a migration
factor in order to construct the final age-specific population
estimates. The population at risk for a given year and a given
commune were subsequently calculated using these estimates.
National age-specific incidence rates based on the National
Registry data were used to derive annual expected numbers of
cases for each age group and commune under study.
The relative risk of leukaemia was estimated by the SIR, defined
as the ratio of observed (O) over expected (E) number of cases. The
95% confidence intervals (CI) for these ratios were given using
Byar’s approximation (Breslow and Day, 1987).
Our principal aim was to investigate the existence of a decrease
in the SIR of childhood leukaemia with increasing distance from
the nuclear installations. This was carried out using three tests as
follows: the likelihood ratio test, a Poisson regression test using
inverse distance and Stone’s Poisson maximum test. The likelihood
ratio test based on the Poisson log-linear regression models test
was used to examine the heterogeneity between predefined areas
around the sites. The second test, also based on the Poisson
regression, uses inverse distance as a surrogate for exposure. This
test belongs to the class of linear risk score tests defined by Bithell
(1995). Stone’s Poisson maximum test follows a nonparametric
approach and is based on the maximum value of the SIR as one
aggregates areas ordered by distance from the site into a region of
increasing size (Stone, 1988). The latter two tests differ from the
likelihood ratio test in that they explicitly test for a decrease in SIR
rather than just testing for heterogeneity. These two tests were
applied to the predefined four area classification around the sites
and also to concentric bands of width 1km.
For all three tests, we used both an external and an internal
reference, alternatively called unconditional and conditional forms
of a test (Morris and Wakefield, 2000). Conditional tests correct for
the local level of risk, thus ignoring the extent to which the overall
observed number of cases around a given site differs from the
overall expected number, and consider only the distribution of
cases within the study region. On the other hand, unconditional
tests are sensitive both to any excess risk in the overall study
region compared to the external reference and to the spatial
pattern of observed cases.
The analysis of childhood leukaemia incidence around all
French nuclear installations was our main objective. However, the
29 sites under study are of different types and there is a strong
effect of age on childhood leukaemia. This probable heterogeneity
called for a more detailed study of childhood leukaemia incidence
around the sites. Analyses were thus carried out according to the
type of site and according to three age groups (0–4, 5–9 and 10–
14 years). For EGNS, additional analyses were performed in order
to consider potential variations according to the electrical power
(1800, 2600–2800, 3600, 5200–5400MWe) and the period of start-
up (before 1980, 1980–1984, 1985–1989, 1990 and later).
Bonferroni’s method was used in order to correct for multiple
testing.
The statistical power of the study for finding an excess of cases
and a decrease in SIR with increasing distance was examined
according to two types of alternative hypotheses using simulation
methods (see Appendix A).
RESULTS
Table 1 shows the distribution of observed and expected cases of
leukaemia among children under 15 years of age around the 29
French nuclear sites. Altogether, 670 cases of childhood leukaemia
were diagnosed within the study area compared to 729.09 expected
cases, this difference is significant at the 5% significance level
(SIR¼0.92, CI¼[0.85–0.99]). At this level, no evidence was found
either of heterogeneity between the four subregions or of a trend of
decreasing SIR with distance from the sites based on the same four
areas. The latter tests also yielded non significant results based on
concentric bands of width 1km.
The sites of Bruye `res, Saclay and Fontenay are located in a very
densely populated area and hence account for 471 cases out of the
total 670. This inevitably influences the overall tests and
calculations in an important way. For this reason, Table 1 also
shows the subtotal referring to the 26 sites excluding this group of
sites (B/S/F) and the main tests were carried out on this subset of
sites as well as on the grand total of 27 sites. There were 199
observed cases around the 26 sites compared to 208.18 expected
cases (SIR¼0.96, CI¼[0.83–1.10]) and, as for all sites, no
evidence was found either of heterogeneity between the four
subregions or of a trend of decreasing SIR with distance from the
sites based on the same four areas.
The numbers of cases according to distance for age groups 0–4,
5–9 and 10–14 years are all lower than expected, although not
significantly so (Table 2). None of the tests showed any significant
association of SIR with distance from the site for any of the age
groups, whether considering all sites or the subset of 26 sites.
Significant evidence of heterogeneity between the 27 sites was
found using the likelihood ratio test (P¼0.038). Indeed individual
analysis of each site (Table 1) showed two occurrences of a
statistically significant excess of cases among children aged 0–14
(Chinon: O¼14, SIR¼2.11, P¼0.0052; Civaux: O¼7, SIR¼2.37,
P¼0.022) and one statistically significant deficit of cases
(Bruye `res/Saclay/Fontenay: O¼471, SIR¼0.90, P¼0.029). These
differences do not remain significant after correcting for multiple
testing (27 comparisons) by Bonferroni’s method. None of the 27
sites present any statistical evidence of a trend in SIR with distance
except for Chinon (P¼0.026) and Creys-Malville (P¼0.039). This
trend is no longer significant after correcting for multiple testing
(27 tests) by Bonferroni’s method. None of the sites showed any
significant heterogeneity between the four subregions except for St
Alban (P¼0.019). No evidence of an interaction between sites and
distance was found using a likelihood ratio test based on Poisson
regression models.
The 19 EGNS were analysed as a group and according to electric
nuclear power and year of start-up. As was the case for the 27 sites’
analysis, no evidence was found of heterogeneity according to
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ydistance or of a decreasing trend in SIR with distance from the
sites, whichever age group was considered.
Table 3 shows the observed and expected numbers of cases as
well as the SIRs according to electric nuclear power, start-up year
and distance. No significant variation of SIR according to electric
nuclear power was found overall or for each of the four study
areas, whether nuclear power was considered quantitatively or
qualitatively. We did neither find any evidence of heterogeneity
between study areas nor of a decreasing trend in SIR according to
distance for any of the classes of nuclear power. Furthermore,
there was no evidence of a significant variation of SIR according to
year of start-up either overall or for each of the four study areas.
No evidence was found of heterogeneity between study areas or of
a trend in SIR according to distance from the site for any of the
start-up year classes.
DISCUSSION
This study was designed to detect any evidence of an increased
incidence of childhood leukaemia around the 29 French nuclear
sites. Overall, the observed number of cases was consistent with
the expected number of cases based on national age-specific
incidence rates and we did not find any statistical evidence of a
decreasing trend in SIR of leukaemia with distance from the sites;
this was true for all ages and for each of the three age groups under
study.
The use of reliable incidence data rather than mortality data
concerning over twice as many nuclear sites considerably
increased the power of this study compared to previous French
multisite studies (Hill and Laplanche, 1990; Hattchouel et al, 1995).
The period, age groups and areas under study, namely children
aged 0–14 years living within 20km of one of the 29 nuclear sites
during the years 1990 to 1998, were all chosen a priori conferring
statistical validity and interpretability to our results. Furthermore,
the issue of the arbitrary choice of subregions for trend tests is
partially solved by the use of Stone’s Poisson maximum test. This
test has the advantage of being adaptive in the sense that it
determines the distance at which the observed effect is maximal
while simultaneously adjusting for this selection.
As our study period was placed between two census dates, we
were able to use interpolation and thus obtain reliable population
estimates. Different methods of interpolation were compared in
order to check the reliability of our estimates. These consistently
gave extremely close results leading us to believe that our
population estimates were largely satisfactory and should not have
influenced our results.
On the one hand, none of the sites presented an increased
incidence of childhood leukaemia except for Chinon and Civaux
and on the other, there was a significant deficit of cases for
Bruye `res/Saclay/Fontenay. One has to bear in mind that a large
number of tests have been carried out. We used Bonferroni’s
method to correct for multiple testing. The excesses of cases at
both Chinon and Civaux and the deficit of cases at Bruye `res/
Saclay/Fontenay were no longer significant by these standards.
Note that the Civaux power plant was in operation for less than 3
years during the study period. Kinlen’s population mixing
hypothesis (1988, 1995) could possibly explain this excess.
However, a much more detailed study, such as that carried out
by Boutou et al (2002) at La Hague, would be necessary in order to
confirm this hypothesis. At Civaux, the SIRs did not decrease
significantly with distance from the site. A significant trend in SIRs
with distance was found at Chinon (P¼0.026); however, the trend
is no longer significant after Bonferroni’s correction. At St Alban,
despite an overall deficit of cases (O¼12, E¼15.72), there was
significant heterogeneity between the four areas under study and
the SIR decreased as distance from the site increased. However,
this trend was not statistically significant.
The pooled analysis of the 19 EGNS was motivated by their
common characteristics. We found no overall excess of cases of
childhood leukaemia near these sites during our study period. The
tests for detecting a decrease in SIR with increasing distance from
the site were not statistically significant. Similar results were
obtained when the start-up year of the nuclear sites and their
electric nuclear power were taken into account.
Levels of education and unemployment rate in the areas around
the sites were found to be similar to the national average, which
means social condition is unlikely to have been a confounding
factor. Other site-specific factors could have influenced our
findings, but using internal references yielded very similar results.
For the pooled analysis of the 27 nuclear sites, the power was
excellent for initial SIRs (i.e. in the 0–5km area) of 2 and 1.5 (96–
100% depending on the test and the alternative hypothesis) and
fair for an initial SIR of 1.2 (40–95% depending on the alternative
hypothesis). All powers were calculated with a 5% probability of
type-I error (see Appendix A).
Table 2 Observed (O) and expected (E) cases of childhood leukaemia living less than 20km away from one of the 29 nuclear sites in France (1990–
1998), with SIR and their 95% CI, according to age and distance from the nuclear sites
Age (years) 0–5km 5–10km 10–15km 15–20km Total
0–4
O 39 95 114 117 365
E 40.04 92.93 136.33 119.27 388.56
SIR 0.97 1.02 0.84 0.98 0.94
95% CI (0.69–1.33) (0.83–1.25) (0.69–1.00) (0.81–1.18) (0.85–1.04)
5–9
O 18 38 64 62 182
E 21.68 49.89 71.32 67.64 210.52
SIR 0.83 0.76 0.90 0.92 0.86
95% CI (0.49–1.31) (0.54–1.05) (0.69–1.15) (0.70–1.18) (0.74–1.00)
10–14
O 8 32 42 41 123
E 13.39 31.48 43.12 42.01 130.00
SIR 0.60 1.02 0.97 0.98 0.95
95% CI (0.26–1.18) (0.70–1.44) (0.70–1.32) (0.70–1.32) (0.79–1.13)
SIR¼standardised incidence ratio; 95% CI¼95% confidence interval.
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yAs in most of the current literature on the subject, our study
shows no evidence of a generally increased risk of childhood
leukaemia within 20km of the 29 nuclear sites under study during
1990–1998. However, the risk associated with continuous and
lasting exposure to very small doses of ionising radiation remains
uncertain, and research on radiation-induced risks is still
necessary. Systematic surveillance of childhood leukaemia inci-
dence around nuclear installations should continue, along with
continuous quantitative measures of dose levels around the sites
and radioecological studies based on exact-dose data.
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Appendix A
The statistical power of the global analysis of the 27 nuclear sites to
detect a decrease in SIR with increasing distance was examined
according to two types of alternative hypotheses, the null
hypothesis being that the SIRs (ri, i¼1,y,4) in the four study
zones (0–5, 5–10, 10–15 and 15–20km) equal 1. The first form of
alternative hypothesis was that the SIRs decreased linearly with
distance according to four initial SIRs, that is, an SIR of 2.0
(respectively 1.5, 1.2 and 1.1) in zone 0–5km declining linearly
with distance to 1.0 in the last zone. Secondly, we considered
alternative hypotheses presenting sharp decreases in SIR with
distance from the site, where the SIR initially takes value r1 in zone
0–5km and then drops to 1. The ‘drop’ was chosen to occur 5, 10
and 15km from the site according to four initial values of the SIR
in the first zone. Hence, there were four alternative hypotheses of
the linear type and 12 of the sharp decrease type.
The above-mentioned null hypothesis was tested using a linear
risk score test with inverse distance as the main parameter and
Stone’s Poisson maximum test. The statistical power of both these
tests for each alternative hypothesis was determined as well as that
of the most powerful (or optimal) test (Bithell, 1995). The statistic
for this last test depends on the real SIRs and hence on the
alternative hypothesis. Under the null hypothesis of a uniform SIR
of 1.0 in all four zones around the sites, the null distributions of the
three tests were determined from 10000 simulations based on the
expected numbers of cases sampled from the appropriate Poisson
distribution. From these null distributions, the 5% critical values
of the test statistics were estimated. Owing to its dependence on
the real SIRs, the optimal test has a different critical value for each
alternative hypothesis. For each of the three tests, 10000
simulations were carried out under each alternative hypothesis.
Childhood leukaemia around nuclear sites in France
ML White-Koning et al
921












yThe proportion of simulated test statistics that exceeded the
critical values provided an estimate of the power of each test to
reject the null hypothesis at the 5% significance level (Table A1).
The statistical powers of the linear risk score test and the
Poisson maximum test were both close to that of the optimal test
under the various alternative hypotheses. The linear risk score test
had greater statistical power than Stone’s Poisson maximum test
for all the patterns of decrease and whatever the initial value of the
SIR, the only exception being the assumption of a sharp decrease
after 5km. This is not surprising considering Stone’s test was
specifically designed for this type of risk pattern. For the pooled
analysis of the 27 nuclear installations, the power was excellent for
initial SIRs of 2 and 1.5, and fair for an initial SIR of 1.2 (with a 5%
probability type-I error). The powers for the detection of an effect
when considering the subset of 26 sites or the 19 EGNS alone were
slightly lower (data not shown).
Table A1 Statistical power of the optimal test, the LRS test and the
Stone’s Poisson maximum test at the 5% significance level according to four
values of the SIR
Optimal test
H1 q1 a0 Power LRS test Poisson max. test
Linear decrease
1.1 4.79 36.98 32.94 19.60
1.2 4.95 84.58 77.78 53.48
1.5 4.71 100.00 100.00 99.89
2 4.99 100.00 100.00 100.00
a0 4.91 3.93
Rapid decrease after 5km
1.1 4.03 19.00 18.18 19.07
1.2 5.34 47.22 40.34 47.27
1.5 4.16 98.40 95.57 98.40
2 5.49 100.00 100.00 100.00
Rapid decrease after 10km
1.1 4.52 43.82 33.43 21.13
1.2 5.05 91.59 78.42 64.60
1.5 4.57 100.00 99.99 99.98
2 4.34 100.00 100.00 100.00
Rapid decrease after 15km
1.1 4.88 71.00 52.59 22.40
1.2 4.84 99.42 95.41 72.33
1.5 4.52 100.00 100.00 100.00
2 4.49 100.00 100.00 100.00
a0 4.83 4.10
LRS test¼linear risk score test; SIR¼standardised incidence ratio. r1 in the 0–5km
zone under two types of alternative hypothesis H1: a linear decrease in SIR and three
forms of rapid decrease in SIR (after 5, 10 or 15km); a0 is the real value of the
probability of type-I error (given by simulation). Note: These calculations are for the
27 site global analysis.
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